Endovascular management of thoracic aortic pathology.
BACKGROUND
Endovascular technology has revolutionised the management of abdominal aortic aneurysmal disease but the less frequent occurrence of pathology in the thoracic aorta has meant that evidence demonstrating the primacy of endovascular treatment strategies in this portion of the vessel is less convincing. Herein we summarise the best available evidence to date.


METHODS
A comprehensive search of the surgical and radiological literature using the search term 'endovascular thoracic aorta' was conducted.


CONCLUSIONS
The vast majority of patients treated by thoracic aortic stent grafting have had their treatment outside the context of a randomised trial. While it would seem that endovascular repair is the treatment of choice for the thoracic aorta, the present evidence is based on single centre case series and is anecdotal at best.
McDonnell
C O
CO
Department ofVascular Surgery, Mater Misericordiae University Hospital, Dublin, Ireland. ciaranomcdonnell@gmail.com
Haider
S N
SN
Colgan
M P
MP
Shanik
G D
GD
Moore
D J
DJ
Madhavan
P
P
D017130:Angioplasty; D001013:Aorta, Thoracic; D001018:Aortic Diseases / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans